Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by OptimizeRx Corporation

< Previous 1 2 Next >
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Third Quarter 2024 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Second Quarter 2024 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports First Quarter 2024 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.